American Red Cross Blood Services Southwest Region FDA Inspection Record

FEI 3006805687 · Inspections, Form 483s, warning letters and import refusals

American Red Cross Blood Services Southwest Region is an FDA-inspected facility (FEI 3006805687) located in Dallas, TX, US. RegDataLab tracks 8 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jul 11, 2024: No Action Indicated (NAI)
Inspections on record
8 (4 VAI, 4 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
5, latest Mar 4, 2024

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jul 11, 2024No Action Indicated (NAI)No citations listed
Jan 31, 2019Voluntary Action Indicated (VAI)Following manufacturer's instructions (21 CFR 606.65(e))
Jan 19, 2017No Action Indicated (NAI)No citations listed
Oct 21, 2014No Action Indicated (NAI)No citations listed
Jun 18, 2014Voluntary Action Indicated (VAI)Following manufacturer's instructions (21 CFR 606.65(e))
Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))
Sep 19, 2013No Action Indicated (NAI)No citations listed
Sep 24, 2012Voluntary Action Indicated (VAI)Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))
Apr 5, 2010Voluntary Action Indicated (VAI)Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 4, 2024Class IIIB-0259-2025Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced, which were not quarantined subsequent to receiving information regarding a post donation illness, were…
Dec 23, 2022Class IIIB-0349-2023Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced
Plateletpheresis products, which were not stored under continuous agitation, were distributed.
Aug 28, 2021Class IIB-0117-2022Red Blood Cells, Leukocytes Reduced, Irradiated
Red Blood Cell, collected from a donor whose arm preparation was not performed in a manner that ensures sterility, was distributed.
Dec 11, 2018Class IIB-0309-2019Red Blood Cells, Leukocytes Reduced
Blood product in which routine testing/testing performed, interpreted, documented, or labeled incorrectly, was distributed.
Mar 23, 2018Class IIIB-0523-2018Blood and Blood Products for Reprocessing
Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.

FDA record score

4 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJan 31, 20196 x 0.251.5
Class II recall B-0117-2022, this FEI as the recalling firmAug 28, 20214 x 0.251
Class II recall B-0309-2019, this FEI as the recalling firmDec 11, 20184 x 0.251
Inspection classified VAIJun 18, 201410 years or older, so it adds no points0
Inspection classified VAISep 24, 201210 years or older, so it adds no points0
Inspection classified VAIApr 5, 201010 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing American Red Cross Blood Services Southwest Region as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check American Red Cross Blood Services Southwest Region yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
American Red Cross Blood Services Southwest Region
Location
Dallas, TX (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.